February 25, 2026
NEW DELHI — In a decisive move to protect the integrity of Indian sports and the health of its competitors, the National Medical Commission (NMC) issued a critical advisory on February 20, 2026. The mandate urges physicians, medical colleges, and hospitals nationwide to exercise extreme caution when prescribing medications to athletes. The directive comes in response to a growing “doping crisis” where common clinical treatments—often prescribed without malice—contain substances prohibited by the World Anti-Doping Agency (WADA), leading to career-ending sanctions for unsuspecting sportsmen and women.
A Growing Menace: India Tops Global Doping List
The urgency of the NMC’s advisory is underscored by a sobering reality: for the third consecutive year, India has reported the highest number of Anti-Doping Rule Violations (ADRVs) globally. According to 2024 data released by the National Anti-Doping Agency (NADA), 260 positive tests were recorded out of 7,113 samples analyzed.
While the positivity rate has dipped from 5.6% in 2019 to 3.6% in 2024 due to intensified testing, the sheer volume of violations remains a significant concern for the Ministry of Youth Affairs and Sports. Athletics led the infraction list with 76 violations, followed closely by weightlifting (43) and wrestling (29).
The “Gatekeeper” Role of Physicians
The NMC, acting on a Ministry directive dated February 6, 2026, has identified medical professionals as the primary “gatekeepers” in this struggle. The advisory mandates that deans, principals, and state medical councils ensure that WADA-prohibited substances are utilized only when medically indispensable and fully documented through official channels.
Understanding the 2026 Prohibited List
As of January 1, 2026, a new WADA Prohibited List is in effect. It categorizes substances based on their pharmacological effects:
-
S1: Anabolic Agents (e.g., testosterone-mimicking steroids)
-
S2: Peptide Hormones (e.g., growth hormones)
-
S4: Hormone and Metabolic Modulators (e.g., insulin, certain breast cancer meds)
-
S6: Stimulants (e.g., adrenaline derivatives, ADHD medications)
Notably, the 2026 update includes new prohibitions on the non-diagnostic use of carbon monoxide and specific stimulants like flmodafinil, which are frequently found in “research chemicals” or unapproved supplements marketed aggressively on social media.
The Trap of Unintentional Doping
Unintentional doping often occurs in the “gray zones” of medicine. A doctor treating a high-level archer for hypertension might prescribe a beta-blocker, unaware that while safe for the general public, it is strictly banned in precision sports like archery and shooting.
“Many clinicians prescribe corticosteroids for inflammation or stimulants for fatigue without cross-referencing the WADA list,” says Dr. Rahul Gupta, a sports medicine specialist at AIIMS New Delhi. “This isn’t just a regulatory issue; it’s a patient safety issue. Anabolic steroids can cause long-term cardiac damage, and unregulated stimulants risk addiction and organ failure. This advisory is a necessary wake-up call for evidence-based prescribing tailored to the unique needs of athletes.”
The Danger of Supplements
The advisory also flags the “wild west” of dietary supplements. Many products sold via YouTube or Instagram are contaminated with unapproved drugs or lack transparent labeling. The NMC has called for stricter enforcement by the Central Drugs Standard Control Organization (CDSCO) and the Food Safety and Standards Authority of India (FSSAI) to prevent these adulterated products from reaching athletes.
Public Health and Ethical Implications
Beyond the stadium, the NMC’s directive aims to foster a culture of medical integrity. For the general public, the over-prescription of performance-enhancing drugs can lead to significant health risks, including hormonal imbalances and psychological distress.
By integrating anti-doping education into the MBBS curriculum and Continuing Professional Development (CPD) programs, the NMC hopes to address a knowledge gap. A recent study published in PMC highlighted that medical students often score suboptimally on anti-doping knowledge tests (averaging 55/100), suggesting that even the next generation of doctors needs better preparation.
The Therapeutic Use Exemption (TUE)
When a prohibited substance is genuinely required for an athlete’s health (such as insulin for a Type 1 diabetic), the Therapeutic Use Exemption (TUE) process exists. However, these must be filed with rigorous documentation—a task that requires doctors to be well-versed in sports-specific regulatory requirements.
Challenges and Limitations
Despite the proactive stance, the advisory faces hurdles:
-
Enforcement: The current guidelines rely largely on voluntary compliance rather than mandatory audits.
-
Resource Access: Doctors in rural or resource-strapped areas may lack consistent access to the latest digital WADA databases.
-
Social Trends: The “fitness influencer” culture continues to drive the demand for supplements that may contain hidden, banned substances.
Practical Guidance for Doctors and Patients
| For Healthcare Providers | For Athletes and Families |
| Check Before You Click: Consult the NADA India App or WADA’s digital Prohibited List before finalizing any prescription for an athlete. | Full Disclosure: Always inform your doctor that you are a competitive athlete subject to drug testing. |
| Document Necessity: If a banned substance is the only viable treatment, assist the athlete in applying for a TUE immediately. | Verify Supplements: Avoid any supplement that isn’t third-party certified for sport (e.g., Informed-Sport). |
| Prioritize Alternatives: Consider physiotherapy or non-prohibited NSAIDs over corticosteroids where clinically appropriate. | The Pharmacist Factor: Ask your pharmacist to double-check ingredients against the “Global DRO” database. |
Looking Ahead
The NMC’s move represents a significant step toward aligning Indian medical practice with international sports standards. By transforming doctors from passive prescribers to active defenders of clean sport, India aims to shed its status as a doping hotspot and ensure that its athletes’ victories are achieved on a level—and healthy—playing field.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References